Stockscreener 앱 받기
4.11
3.75%
-0.16
시간 외 거래:
4.15
0.04
+0.97%
전일 마감가:
$4.27
열려 있는:
$4.27
하루 거래량:
755.98K
Relative Volume:
0.72
시가총액:
$787.88M
수익:
$12.99M
순이익/손실:
$-74.39M
주가수익비율:
-9.3409
EPS:
-0.44
순현금흐름:
$-78.92M
1주 성능:
-6.16%
1개월 성능:
-11.04%
6개월 성능:
+31.73%
1년 성능:
+8.44%
1일 변동 폭
$4.10
$4.30
1주일 범위
$4.10
$4.535
52주 변동 폭
$2.705
$5.10
Arbutus Biopharma Corp Stock (ABUS) Company Profile
명칭
Arbutus Biopharma Corp
전화
604-419-3200
주소
701 VETERANS CIRCLE, WARMINSTER, PA
ABUS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.11 | 818.55M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-02-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-02-25 | 개시 | Jefferies | Hold |
| 2020-12-17 | 개시 | H.C. Wainwright | Buy |
| 2020-07-27 | 재개 | JMP Securities | Mkt Outperform |
| 2020-07-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2020-03-06 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | 개시 | Robert W. Baird | Outperform |
| 2020-02-05 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | 재확인 | B. Riley FBR | Buy |
| 2019-10-04 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | 업그레이드 | Wedbush | Underperform → Neutral |
| 2018-10-12 | 재확인 | Chardan Capital Markets | Buy |
| 2018-07-06 | 다운그레이드 | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | 재개 | Chardan Capital Markets | Buy |
| 2018-03-19 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-01-05 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | 재확인 | Wedbush | Outperform |
| 2016-12-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
모두보기
Arbutus Biopharma Corp 주식(ABUS)의 최신 뉴스
Risk adjusted return profile for Arbutus Biopharma Corporation analyzedPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Arbutus Announces Four Abstracts Accepted for Presentation at AASLDThe Liver Meeting® 2025 - GlobeNewswire
Arbutus Biopharma (ABUS) Showcases Promising Liver Disease Resea - GuruFocus
Has Arbutus Biopharma Corporation formed a bullish divergenceQuarterly Trade Report & Technical Pattern Recognition Alerts - newser.com
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year? - Yahoo Finance
Applying Wyckoff theory to Arbutus Biopharma Corporation stockWeekly Trend Report & Fast Gain Stock Tips - newser.com
Is Arbutus Biopharma Corporation forming a reversal pattern2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
Risk vs reward if holding onto Arbutus Biopharma CorporationRate Cut & Real-Time Volume Analysis - newser.com
Is Arbutus Biopharma Corporation stock a buy on dipsGap Down & Daily Risk Controlled Trade Plans - newser.com
Statistical indicators supporting Arbutus Biopharma Corporation’s strengthWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Voya Investment Management LLC Sells 4,534 Shares of Arbutus Biopharma Corporation $ABUS - Defense World
Will Arbutus Biopharma Corporation stock deliver better than expected guidanceShort Setup & Long Hold Capital Preservation Plans - newser.com
Arbutus Biopharma's CFO David Hastings sells shares worth $72,826 - MSN
Assenagon Asset Management S.A. Makes New $122,000 Investment in Arbutus Biopharma Corporation $ABUS - Defense World
Is Arbutus Biopharma Corporation reversing from oversold territoryJuly 2025 WrapUp & Fast Gain Stock Tips - newser.com
Arbutus Biopharma Corporation Stock Analysis and ForecastEarnings Miss Alerts & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Does Arbutus Biopharma Corporation fit your quant trading modelJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Can machine learning forecast Arbutus Biopharma Corporation recoveryJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
Building trade automation scripts for Arbutus Biopharma Corporation2025 Price Momentum & Verified Trade Idea Suggestions - newser.com
What MACD signals say about Arbutus Biopharma Corporation2025 Historical Comparison & Stepwise Trade Signal Implementation - newser.com
Analyzing drawdowns of Arbutus Biopharma Corporation with statistical tools2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
What machine learning models say about Arbutus Biopharma Corporation2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
Arbutus Biopharma Corporation stock volume spike explainedQuarterly Risk Review & High Win Rate Trade Alerts - newser.com
Is Arbutus Biopharma Corporation stock bottoming outLong Setup & Weekly Setup with ROI Potential - newser.com
what machine learning models say about arbutus biopharma corporationJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
Using economic indicators to assess Arbutus Biopharma Corporation potential2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Aug Setups: Whats next for Arbutus Biopharma Corporation stockLong Setup & Weekly Breakout Watchlists - خودرو بانک
Reversal indicators forming on Arbutus Biopharma Corporation stockQuarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com
Arbutus Biopharma Corporation $ABUS Shares Purchased by Goldman Sachs Group Inc. - MarketBeat
Aug Rallies: Is Arbutus Biopharma Corporation stock a top performer YTD2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
RSI Check: Should I set a stop loss on RELYMarket Performance Report & Free Community Consensus Stock Picks - خودرو بانک
Arbutus: IP Drama With High Stakes (NASDAQ:ABUS) - Seeking Alpha
Fundamentals Check: What’s next for Arbutus Biopharma Corporation stockWeekly Volume Report & Risk Controlled Daily Trade Plans - خودرو بانک
Published on: 2025-09-15 00:38:22 - newser.com
Arbutus Biopharma Corp (ABUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):